Evidence map›Paper›PMID 28186095›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.

Amanda B Zheutlin, Clark D Jeffries, Diana O Perkins, Yoonho Chung, Adam M Chekroud, Jean Addington, Carrie E Bearden, Kristin S Cadenhead, Barbara A Cornblatt, Daniel H Mathalon and 6 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 2 countries.

Amanda B ZheutlinDepartment of Psychology, Yale University, New Haven, CT, USA.
Clark D JeffriesRenaissance Computing Institute, University of North Carolina, Chapel Hill, NC, USA.
Diana O PerkinsDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.
Yoonho ChungDepartment of Psychology, Yale University, New Haven, CT, USA.
Adam M ChekroudDepartment of Psychology, Yale University, New Haven, CT, USA.
Jean AddingtonDepartment of Psychiatry, University of Calgary, Alberta, Canada.
Carrie E BeardenDepartment of Psychiatry &Biobehavioral Sciences, University of California-Los Angeles, Los Angeles, CA, USA.
Kristin S CadenheadDepartment of Psychiatry, University of California-San Diego, San Diego, CA, USA.
Barbara A CornblattDepartment of Psychiatry, Zucker Hillside Hospital, Long Island, NY, USA.
Daniel H MathalonDepartment of Psychiatry, University of California-San Francisco, San Francisco, CA, USA.
Thomas H McGlashanDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Larry J SeidmanDepartment of Psychiatry, Beth Israel Deaconess Medical Center and Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Elaine F WalkerDepartment of Psychology, Emory University, Atlanta, GA, USA.
Scott W WoodsDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Ming TsuangDepartment of Psychiatry, University of California-San Diego, San Diego, CA, USA.
Tyrone D CannonDepartment of Psychology, Yale University, New Haven, CT, USA.
Yale University · USUniversity of California, San Diego · USEmory University · USHarvard University · USRenaissance Computing Institute · USUniversity of Calgary · CAUniversity of California, Los Angeles · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USZucker Hillside Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
5/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082004 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PERKINS, DIANA O. · 2008 to 2018
$7.5M
Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
6/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081944 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CADENHEAD, KRISTIN S. · 2008 to 2018
$4.9M
"7/9" Predictors and Mechanisms of Conversion to PsychosisU01MH081984 · NIMH · UNIVERSITY OF CALGARY · PI ADDINGTON, JEAN M · 2008 to 2018
$4.2M
9/9-Predictors and Mechanisms of Conversion to PsychosisU01MH076989 · NIMH · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MATHALON, DANIEL H · 2014 to 2018
$3.9M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS U01 MH076989NIMH NIH HHS U01 MH081857NIMH NIH HHS U01 MH081902NIMH NIH HHS U01 MH081928NIMH NIH HHS U01 MH081944NIMH NIH HHS U01 MH081984NIMH NIH HHS U01 MH081988NIMH NIH HHS U01 MH082004NIMH NIH HHS U01 MH082022
6 · The paper itself

Abstract

In a recent report of the North American Prodrome Longitudinal Study (NAPLS), clinical high-risk individuals who converted to psychosis showed a steeper rate of cortical gray matter reduction compared with non-converters and healthy controls, and the rate of cortical thinning was correlated with levels of proinflammatory cytokines at baseline. These findings suggest a critical role for microglia, the resident macrophages in the brain, in perturbations of cortical maturation processes associated with onset of psychosis. Elucidating gene expression pathways promoting microglial action prior to disease onset would inform potential preventative intervention targets. Here we used a forward stepwise regression algorithm to build a classifier of baseline microRNA expression in peripheral leukocytes associated with annualized rate of cortical thinning in a subsample of the NAPLS cohort (N=74). Our cortical thinning classifier included nine microRNAs, p=3.63 × 10

Indexed as

Prodromal SymptomsAdolescentAdultAlgorithmsCerebral CortexCohort StudiesCytokinesFemaleGene Expression Regulation, DevelopmentalHumansLeukocytesMaleMicrogliaMicroRNAsPredictive Value of TestsPsychotic DisordersCytokinesMicroRNAs

Identifiers

PMID28186095
PMCPMC5603810
OpenAlexW2587565910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.